Rodolphe J. Poussot - 18 Feb 2026 Form 4 Insider Report for WEST PHARMACEUTICAL SERVICES INC (WST)

Role
SVP, Strategy & Corporate Dev
Signature
/s/ Louis Lalli, as an agent for Rodolphe J. Poussot
Issuer symbol
WST
Transactions as of
18 Feb 2026
Net transactions value
-$6,904
Form type
4
Filing time
19 Feb 2026, 19:05:52 UTC
Previous filing
01 Aug 2025
Next filing
23 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Poussot Rodolphe Jean SVP, Strategy & Corporate Dev 530 HERMAN O. WEST DRIVE, EXTON /s/ Louis Lalli, as an agent for Rodolphe J. Poussot 19 Feb 2026 0002079538

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction WST Common Stock Options Exercise +82 +33% 335 18 Feb 2026 Direct F1
transaction WST Common Stock Tax liability $6,904 -28 -8.3% $248.26 307 18 Feb 2026 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction WST Rst. Stock Unit Options Exercise $0 -82 -25% $0.000000 248 18 Feb 2026 Common Stock 82 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units convert into common stock on a one-for-one basis.
F2 On February 18, 2025, the reporting person was granted 329 restricted stock units, vesting in four equal annual installments (plus dividend equivalents).